![](https://investorshub.advfn.com/uicon/691940.png?cb=1578604518)
Monday, January 14, 2019 10:10:13 PM
Condition postoperative pain
Treatments recoveryrx, sham recoveryrx
Sponsor BioElectronics Corporation
Start date April 2018
End date December 2018
Trial size 250 participants
Trial identifier NCT03604068,
https://www.smartpatients.com/trials/NCT03604068
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM